(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PRIONEX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PRIONEX

ST13

US500000088276839

Class

1, 5

Filing

88276839

Registration

6217325

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

12/09/2025

Trademark type

Word

Nice classes

1, 5

Filing date

01/25/2019

Registration date

12/08/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/08/2020

Last transaction

12/09/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

1992-00-00

First use in commerce

2012-00-00

Drawing code

4

Owner type

25

Owner location

AESCH BL, CH

Examiner

GOODSAID, IRA

Law office

L10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

PENTAPHARM AG
DSM IP Assets B.V.

Representatives

Duane M. Byers NIXON & VANDERHYE PC

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Diagnostic preparations for scientific or research use; Chemical additives for use in the manufacture of pharmaceuticals

Class 5

Diagnostic preparations for medical purposes; Pharmaceutical preparationspolypeptide fractions of porcine collagen for use in protein stabilization and for use in tissue culture and cell culture

Publications

History of USPTO decisions and trademark events.

37 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/08/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/01/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

12/08/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

10/31/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/30/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/30/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/30/2020

IUAF

USE AMENDMENT FILED

10/14/2020

EISU

TEAS STATEMENT OF USE RECEIVED

10/14/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/28/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/03/2020

PUBO

PUBLISHED FOR OPPOSITION

03/03/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/12/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/29/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/24/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/24/2020

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

01/22/2020

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

07/30/2019

GRML

CORRESPONDENCE E-MAILED

07/29/2019

NAUD

REPORT UNRESPONSIVE AMENDMENT - COMPLETED

07/29/2019

IUAA

USE AMENDMENT ACCEPTED

07/29/2019

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

07/29/2019

IUAF

USE AMENDMENT FILED

07/29/2019

EAAU

TEAS AMENDMENT OF USE RECEIVED

07/28/2019

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

07/22/2019

GNFR

FINAL REFUSAL E-MAILED

07/22/2019

CNFR

FINAL REFUSAL WRITTEN

07/22/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/20/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/20/2019

ALIE

ASSIGNED TO LIE

07/20/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/16/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/15/2019

GNRT

NON-FINAL ACTION E-MAILED

03/15/2019

CNRT

NON-FINAL ACTION WRITTEN

03/15/2019

DOCK

ASSIGNED TO EXAMINER

03/14/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/17/2019

NWAP

NEW APPLICATION ENTERED

01/29/2019

Continuous trademark protection

Get notified about every new filing that threatens PRIONEX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.